Financial risk management activities |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of detailed information about financial instruments [abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial risk management activities | Financial risk management activities Fair value Fair value is determined using valuation techniques as outlined below, unless the instrument is traded in an active market. Where possible, inputs are based on quoted prices and other market determined variables. Fair value hierarchy The Group uses the following hierarchy for determining and disclosing the fair value of financial instruments: •Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities; •Level 2: inputs other than quoted prices included in level 1 that are observable for the asset or liability, either directly (as prices) or indirectly (derived from prices); and •Level 3: inputs for the asset or liability that are not based on observable market data (unobservable inputs). 11 Financial risk management activities (continued) The table below represents financial instruments measured at fair value at the reporting date, or for which fair value is disclosed at 30 June 2025.
(1) Included in the statement of financial position in current and non-current trade, other receivables and other assets. (2) The line item description has been changed from deferred consideration asset to contingent consideration asset to align more with the nature of the receivable and to clearly distinguish from receivables that are deferred but not contingent. Reconciliation of contingent consideration assets A reconciliation of the contingent consideration asset included in the statement of financial position is set out in the following table:
11 Financial risk management activities (continued) Sensitivity analysis Contingent consideration – Mponeng As at 30 June 2025, the contingent consideration asset ($19m) was valued using a discount rate of 7.3% (2024: 8.0%) and production plans over the period as received from Harmony. The fair value calculated for the contingent consideration asset is level 3 in the fair value hierarchy due to the use of unobservable inputs. As at 30 June 2025, no portion of the contingent consideration related to Harmony developing below infrastructure has been included in the contingent consideration asset as this project is at an early stage. A reasonable possible change in the number of ounces used in the probability weighted calculation would not have a material impact on the fair value of the contingent consideration asset. Contingent consideration – Gramalote As at 30 June 2025, the contingent consideration asset ($26m) was valued using a discount rate of 9.4% (2024: 9.4%) and future stage gate payments as per the purchase agreement. The assumptions used in the valuation included the timing and probability of contingent considerations. A reasonable possible change in the assumptions used in the probability weighted calculation would not have a material impact on the fair value of the contingent consideration asset. Contingent consideration – Mansala and ABC As at 30 June 2025, the contingent consideration asset ($34m) was valued using a discount rate of 9.0% for Mansala and 12.0% for ABC and future contingent considerations as per the purchase agreement. The assumptions used in the valuation included the timing and probability of contingent considerations. A reasonable possible change in the assumptions used in the probability weighted calculation would not have a material impact on the fair value of the contingent consideration asset.
|